It has rarely been this hectic at the start of a year for Hong Kong’s equity markets. In January alone, companies raised about $5 billion through initial public offerings, the highest total ever recorded for the month, according to data compiled by Bloomberg. Thirteen companies debuted on the exchange in just a few weeks, spanning artificial intelligence chip designers, large language model developers and even a snack retailer, underscoring the breadth of sectors now willing to test investor appetite.
The surge marks a striking acceleration from recent years and is widely seen as evidence that Hong Kong’s long-awaited recovery as a global fundraising hub is gaining traction. After a bruising period marked by China’s technology crackdown, geopolitical friction and a collapse in deal flow, the city staged a tentative comeback last year, recording its strongest annual IPO proceeds since 2021. The pace at the start of 2026 suggests that momentum may not only be intact but strengthening.
Confidence is being reinforced by the size of the pipeline. More than 350 companies are currently waiting to list in Hong Kong, according to Hong Kong Exchanges & Clearing chief executive officer Bonnie Chan, who said in an interview last month that interest remains robust across industries. Consultancy KPMG estimates that total listing proceeds this year could reach $45 billion, a six-year high if realised. For global banks and fund managers starved of Asian equity issuance, the numbers are hard to ignore.
“This year should, all else being equal, be busier and more active than last year,” said Saurabh Dinakar, head of Asia-Pacific global capital markets at Morgan Stanley. He pointed to renewed optimism around China’s technology, media and telecommunications sectors, alongside innovation in healthcare, as key drivers of sentiment. Valuations have also played a decisive role. Hong Kong- and mainland-listed shares are trading at a significant discount to their US peers, making the region increasingly attractive to value-conscious investors.
A widely followed gauge of Hong Kong-listed Chinese companies is currently priced at about 11 times estimated earnings, roughly half the valuation multiple of the S&P 500. That gap has helped lure global capital back to the city, particularly as expectations grow that interest rates in the US may ease later in the year. For many investors, Hong Kong is once again being viewed less as a geopolitical risk zone and more as a discounted gateway to China’s next phase of growth.
Much of January’s record haul was driven by high-profile Chinese technology firms. Deals involving OpenAI challenger MiniMax Group and chip designer Shanghai Biren Technology stood out, highlighting Beijing’s continued support for technological self-reliance amid intensifying competition with the United States. The listings sent a clear signal that companies aligned with China’s strategic priorities can still attract capital, even as Washington seeks to curb Beijing’s access to advanced technology.
Sustaining the momentum will be critical. Hong Kong’s IPO market has experienced false dawns before, most notably after the exuberant rush of 2021, when ultra-low borrowing costs and soaring valuations fuelled a listings boom that abruptly ended with China’s regulatory crackdown on its tech giants. This time, market participants say the tone is markedly different.
“This is not the kind of exuberance we saw in 2021, when deals were heavily oversubscribed and the market quickly moved on from one transaction to the next,” Dinakar said. “The companies coming to market today are, by and large, very good companies, and interest is being driven by fundamentals.” That more disciplined approach is widely viewed as a healthier foundation for a sustained recovery.
For some investors, the shift in quality has been palpable. Nicholas Chui, a portfolio manager at Franklin Templeton, said he participated in roughly a third of January’s listings and around a dozen deals over the past year, the most active period of his career. He said his confidence was bolstered by a process of natural selection: companies tapping the market now have survived years of scepticism about China’s investability.
The structure of the market has also changed. In previous cycles, a flood of IPOs often drained liquidity from secondary markets, depressing share prices of existing listings. This time, Chui said, there appears to be sufficient capacity to absorb new supply. His China-focused funds, which manage about $700 million, have not seen the same crowding-out effects that once plagued periods of intense issuance.
Returns have rewarded that confidence. January’s new listings have delivered a weighted-average gain of more than 70%, significantly outperforming broader market indexes. The rally has drawn in US investors, even as political tensions between Washington and Beijing simmer. JPMorgan Asset Management Holdings has signed on as a cornerstone investor in the upcoming IPO of Chinese chip designer Montage Technology, a move that underscores the enduring appeal of select Chinese assets despite strategic rivalry.
Banks are already looking beyond the first quarter. Market participants are watching potential blockbuster deals, including possible IPOs of artificial intelligence chip units from Alibaba Group Holding and Baidu. At the same time, second listings of Chinese companies, which formed the backbone of last year’s rebound, continue to populate the pipeline, providing a steady flow of medium-sized transactions.
The frenetic activity has spilled into adjacent markets. About $5.9 billion of bonds convertible into shares were sold by Asia-Pacific companies in January, the strongest start to a year since 2018. Many of the issuers were Chinese miners capitalising on soaring metal prices, highlighting how buoyant equity sentiment is feeding into broader capital-raising strategies.
Yet risks remain. The pace of deals over the rest of the year may depend on factors beyond bankers’ control, particularly regulatory shifts. According to people familiar with the matter, China’s securities regulator has been weighing higher compliance and disclosure thresholds for firms seeking so-called H-share listings in Hong Kong. Any tightening could slow the pipeline just as momentum is building.
Timing has therefore become critical. Many companies that secured approval from the China Securities Regulatory Commission in December are racing to complete their offerings before the Lunar New Year holiday in mid-February, when trading activity typically slows. Richard Wang, a partner and head of China equity capital markets at law firm Freshfields, said firms are eager to strike while market conditions remain favourable.
For now, the numbers tell a powerful story. As Bloomberg data show, Hong Kong has started the year with a burst of activity unmatched in its recent history. Whether that surge evolves into a durable renaissance will depend on policy stability, global risk appetite and the ability of listed companies to deliver on their promises. But after years of uncertainty, investors are once again watching the city not as a cautionary tale, but as a market in revival.
